Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Panel approves ban on prior authorization for opioid-use-disorder medications with two-year review
Summary
The committee unanimously approved an amended bill to remove prior authorization for FDA-approved medications to treat opioid use disorder; the amendment limits coverage to medications FDA-approved by Jan. 1, 2025, and adds a two-year sunset and reporting/guardrails.
Representative King presented House Bill 11-12, which would remove prior authorization requirements for medications used to treat opioid use disorder (OUD). King said the change aims to stop treatment delays that lead to relapses, reincarcerations and fatal overdoses, and offered an amendment to add guardrails: the bill applies only to medications that were FDA-approved by Jan. 1, 2025, and includes a two-year sunset to allow evaluation of costs and outcomes.
Joey Fox, representing the Pharmaceutical…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
